FDA Adverse Event Death Summary report: N

XIENCE PRIME SV EVEROLIMUS ELUTING CORONARY STENT SYSTEM

MDR report key: 4093622 · Received September 16, 2014

Report

Report Number
2024168-2014-05960
Event Type
Death
Date Received
September 16, 2014
Date of Event
January 1, 2014
Report Date
August 22, 2014
Manufacturer
AV-TEMECULA-CT
Product Code
NIQ
PMA / PMN Number
P110019
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
JA
Reporter Occupation
HEALTH PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

(B)(4). DURING PROCESSING OF THIS COMPLAINT, ATTEMPTS WERE MADE TO OBTAIN COMPLETE EVENT, PATIENT AND DEVICE INFORMATION. THERE WAS NO REPORTED DEVICE MALFUNCTION AND THE PRODUCT WAS NOT RETURNED. CARDIAC ARREST AND DEATH ARE LISTED IN THE XIENCE PRIME EVEROLIMUS ELUTING CORONARY STENT SYSTEMS INSTRUCTIONS FOR USE (IFU) AS KNOWN PATIENT EFFECTS OF CORONARY STENTING PROCEDURES. ALTHOUGH A CONCLUSIVE CAUSE FOR THE REPORTED PATIENT EFFECTS, AND THE RELATIONSHIP TO THE PRODUCT, IF ANY, CANNOT BE DETERMINED, THERE IS NO INDICATION OF A PRODUCT QUALITY DEFICIENCY WITH RESPECT TO MANUFACTURING, DESIGN OR LABELING.

Additional Manufacturer Narrative · 1

(B)(4).

Description of Event or Problem · 1

IT WAS REPORTED THAT ON 10/31/2013 A 2.25 X 18 MM XIENCE PRIME SV WAS IMPLANTED IN A HIGH LATERAL BRANCH AND A 2.75 X 8 MM XIENCE XPEDITION WAS IMPLANTED IN THE DISTAL RIGHT CORONARY ARTERY. ON (B)(6) 2014 THE PATIENT PRESENTED WITH CARDIOPULMONARY ARREST. CARDIOPULMONARY RESUSCITATION (CPR) WAS PERFORMED; HOWEVER, THE PATIENT EXPIRED. AN AUTOPSY WAS NOT PERFORMED. NO ADDITIONAL INFORMATION WAS PROVIDED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
573296 XIENCE PRIME SV EVEROLIMUS ELUTING CORONARY STENT SYSTEM DRUG ELUTING CORONARY STENT SYSTEM NIQ AV-TEMECULA-CT

Patients

Seq Age Sex Outcome Treatment
1 79 YR Death STENT: 2.75 X 8 XIENCE XPEDITION